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ABSTRACT Fusarium moniliforme toxins (fumonisins)
and Alternaria alternata lycopersici (AAL) toxins are members
of a new class of sphinganine analog mycotoxins that occur
widely in the food chain. These mycotoxins represent a serious
threat to human and animal health, inducing both cell death
and neoplastic events in mammals. The mechanisms by which
this family of chemical congeners induce changes in cell
homeostasis were investigated in African green monkey kid-
ney cells (CV-1) by assessing the appearance of apoptosis, cell
cycle regulation, and putative components of signal transduc-
tion pathways involved in apoptosis. Structurally, these my-
cotoxins resemble the sphingoid bases, sphingosine and sphin-
ganine, that are reported to play critical roles in cell commu-
nication and signal transduction. The addition of fumonisin
B1 or AAL toxin, TA, to CV-1 cells induced the stereotypical
hallmarks of apoptosis, including the formation of DNA
ladders, compaction of nuclear DNA, and the subsequent
appearance of apoptotic bodies. Neither mycotoxin induced
cell death, DNA ladders, or apoptotic bodies in CV-1 cells
expressing simian virus 40 large T antigen (COS-7) at toxin
concentrations that readily killed CV-1 cells. Fumonisin B1
induced cell cycle arrest in the G1 phase in CV-1 cells but not
in COS-7 cells. AAL toxin TA did not arrest cell cycle
progression in either cell line. The induction of apoptosis
combined with the widespread presence ofthese compounds in
food crops and animal feed identifies a previously unrecog-
nized health risk to humans and livestock. These molecules
also represent a new class ofnatural toxicants that can be used
as model compounds to further characterize the molecular
and biochemical pathways leading to apoptosis.
Fumonisins and Alternaria alternata lycopersici (AAL) toxins,
a recently discovered group of mycotoxins structurally related
to sphinganine, are produced by Fusarium moniliforme (1-5)
and strains of Alternaria alternata (6, 7), respectively (Fig. 1).
These fungi are ubiquitous saprophytes and economically
important pathogens of many food crops. F. moniliforme
causes both stalk and ear rot of maize worldwide. Fumonisin
contamination has been detected in substantial amounts (>4
,uM) in 74% of corn in the United States and in all areas of the
world where corn is produced, with levels ranging as high as 2
mM or greater (3, 4, 8-10). The incidence of contamination of
maize by the fumonisins is exacerbated by the endophytic life
style of the fungus, which enables the fungus and its toxin to
be present in maize plants and stored grain in the absence of
visible disease symptoms (9).
Ingestion of fumonisins through contaminated feed, or as
pure fumonisin B1 (FB1), induces a variety of responses in the
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FIG. 1. Structures of sphinganine, fumonisin B1, and AAL toxin
TA1.
challenged animals including neuro-, renal, and heptatoxicosis
and neoplasms as well as cell death (4, 11-13). Consumption
of fumonisin-contaminated corn also has been linked to
esophageal cancer in humans in the Transkei region of South
Africa, China, and other countries (14). Because of the fre-
quency and level of contamination in maize and the toxicity of
fumonisin to animals, serious concern has developed over the role
of this mycotoxin in animal and human disease. AAL toxins play
an important role in the stem-canker disease of tomatoes but a
role in animal disease is, at present, unresolved (15).
At present little is known concerning the mechanism by
which these mycotoxins induce toxigenic or carcinogenic ef-
fects. The structural relationship to sphinganine, an interme-
diate in the biosynthesis of the sphingosine backbone of more
complex sphingolipids such as ceramides, sphingomyelin ce-
rebrosides, gangliosides, and sulfatides, is the basis for current
models linking mode of action to alterations in the synthesis of
sphingoid bases (16, 17). There is considerable evidence that
ingestion of these mycotoxins leads to disruption of sphingo-
lipid metabolism (18-20). An important site of inhibition is the
reaction catalyzed by sphingosine N-acetyltransferase (cera-
mide synthase). Both FB1 and AAL toxin TA (TA) inhibited
ceramide synthase in rat hepatocytes (16) and in microsomal
preparations from green tomato fruit (21).
Abbreviations: AAL, Alternaria alternata lycopersici; FB1, fumonisin
B1; TA, AAL toxin TA; PKC, protein kinase C; SV40, simian virus 40;
TUNEL, terminal deoxynucleotidyltransferase end labeling.
tH.W. and C.J. contributed equally to this work.
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Sphingolipids have been implicated as playing a role in cell
contact, growth, and differentiation (22). Sphingolipids also
can influence the proliferative potential of mammalian cells by
induction or suppression of apoptosis, a specific form of
programmed cell death (23). Recent findings suggest the
regulatory coupling of proliferation and mitosis to apoptosis
(24-26). Based on the fact that fumonisins and AAL toxins
resemble sphingoid bases, such compounds could elicit cell
death or carcinogenesis by inducing apoptosis and/or by
altering the cell cycle.
We reported previously that FBI repressed expression of
two isoforms of protein kinase C (PKC) (a and 0) in cultured
African green monkey kidney cells (CV-1) and inhibited
transcription by activator protein 1 (AP-1) 10-fold within 3 hr
after toxin treatment (27). These results identified possible
molecular targets of this toxin and suggested that inappropri-
ate regulation of signal transduction pathways associated with
apoptosis may be responsible for the deleterious effects of FB,
in CV-1 cells.
In this report we provide evidence that FB1 and TA induce
apoptosis in CV-1 cells and that FBI but not TA arrests the
treated cells in the G1 phase of the cell cycle. Moreover, CV-1
cells transformed by the simian virus 40 (SV40) large T antigen
(COS-7) are unaffected by the same levels of FB1 or TA. Since
large T antigen has pleiotropic effects on cell cycle regulation
and induction of apoptosis (reviewed in ref. 28), large T
antigen may overcome the antiproliferative and apoptotic
properties of FB1.
MATERIALS AND METHODS
Fumonisin and TA. FB1 was purchased from Sigma (>98%
pure) or was a generous gift from R. D. Plattner (U.S.
Department of Agriculture, Peoria, IL) (>90% pure). Both
preparations gave identical results. AAL toxin TA was pro-
duced and purified as described (7).
Cells and Media. CV-1 cells and African green monkey
kidney cells, were obtained from Robert Su (National Insti-
tutes of Health). COS-7 cells were obtained from American
Type Culture Collection. Cells were grown in Earle's modified
Eagle's medium supplemented with 5% fetal bovine serum.
All media contained penicillin (10 units/ml) and streptomycin
(100 Ztg/ml).
Histochemical Detection of Nuclear DNA Fragmentation
and Apoptotic Bodies. The terminal deoxynucleotidyltrans-
ferase end-labeling (TUNEL) technique was used for in situ
evaluation of CV-1 and COS-7 cells for DNA fragmentation
and the appearance of apoptotic bodies (29). Slides were
stained with DNA counterstains, Hoechst 33342 (Sigma), and
propidium iodide. The slides were viewed under a Nikon SA
fluorescence microscope and view-fields were captured by
C-Imaging System (Compix, Cranberry Twp., PA).
Cell Cycle Analysis. Cells were plated at a density of 5 x 105
cells per 100-mm dish and allowed to attach to the dish for 3
hr prior to treatment with FB, or TA. Cells were prepared for
flow cytometry by scraping monolayers from tissue culture
dishes, washing the cells in isotonic buffer, and resuspending
in Vindelov's reagent (40 mM Tris, pH 7.6/100 mM NaCl/10
pug of RNase A per ml/7.5% propidium iodide/0.1% Nonidet
P-40). Flow cytometry was conducted at the Cell Analysis Core
Facility at the University of Nebraska Medical Center using a
Becton Dickinson Cell Sorter.
RESULTS
The pivotal roles assigned currently to apoptosis for mainte-
nance of cell stability (23) and of lipid-based signal molecules
in regulation of apoptosis (30) suggested the action of FB1 and
TA involve apoptosis as the functional paradigm of cell death.
CV-1 and COS-7 cells were chosen as models to study the
effects of FBI and TA on apoptosis because they are well
characterized cell lines. CV-1 cells have many features of
normal cells because they are not tumorigenic, do not grow in
soft agar, and are contact inhibited. In contrast, COS-7 cells
which contain large T antigen, are tumorigenic, grow in soft
agar, and are not contact inhibited.
Appearance of DNA Ladders and Apoptotic Bodies. CV-1
and COS-7 cells were treated with either FB, or TA at various
concentrations and analyzed over time for the presence of
ordered DNA fragmentation and apoptotic bodies. To deter-
mine whether FBI or TA induced cell death with features
consistent with apoptosis, toxin treated CV-1 cells were la-
beled with digoxigenin-dUTP by terminal deoxynucleotidyl-
transferase using the TUNEL procedure and stained for total
nuclear DNA. Free 3'-OH groups, generated during the
endonuclease-catalyzed DNA fragmentation, were detected
by fluorescein-conjugated anti-digoxigenin antibodies and vi-
sualized by fluorescence microscopy in cells treated with either
FB1 or TA. Propidium iodide, a vital dye (31), was added to the
cell cultures to permit visualization of DNA in dying cells,
which could then be outlined against the fragmented DNA
detected by the TUNEL reaction. Apoptotic bodies arising
from apoptotic nuclei appear subsequent to the detection of
DNA fragmentation. The combined use of propidium iodide
and Hoescht enabled confirmation of the presence ofTUNEL-
positive signal based on fluorescein isothiocyanate (FITC)
fluorescence. Propidium iodide suppressed the natural
autofluorescence of the cell which was excited at the same
wavelength as FITC and interfered with FITC unless sup-
pressed by propidium iodide. Within 3 hr after treatment of
CV-1 cells with either FBI or TA at 1 ,gM, both DNA ladders
(Fig. 2) and apoptotic bodies were detected (Fig. 3). Temporal
analysis of DNA fragmentation by agarose gel electrophoresis
indicated that smaller sized fragments (180 bp) increased in
abundance up to 24 hr after toxin treatment. The lowest
concentration of FBI or TA tested that induced these effects
was 10 nM where the observed TUNEL-positive cells were
10% (3 hr), 15% (6 hr), and 30% (24 hr) at the indicated time
points. In separate experiments, the counting of >5000 indi-
vidual CV-1 cells treated with FB, or TA revealed 45% and
74% TUNEL-positive cells, respectively, at 2 and 5 ,uM,
compared to 4% in the untreated control (least significant
difference = 3%). There were no apparent differences in the
kill rate or number of apoptotic cells between the two myco-
toxins at any concentration tested.
C 1 2 3 456
FIG. 2. Southern blot analysis ofDNA ladders induced by FB1 and
TA. CV-1 cells were treated with 5 ,uM FBI or TA for various time
periods. DNA was extracted and subjected to agarose gel electro-
phoresis and analyzed by Southern blot hybridization with total
monkey DNA. Control (C) and cells treated with FB1 (lanes 1-3 were
sampled at 3, 6, and 24 hr, respectively) and TA (lanes 4-6 were
sampled at 3, 6, and 24 hr, respectively). Arrowheads mark 500- and
1000-bp locations based on ethidium bromide staining of DNA size
markers run on the original gel.
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FIG. 3. In situ detection of fragmented nuclear DNA in CV-1 cells treated with FB1 and AAL toxin TA. (Upper) Toxin-treated CV-1 DNA
that has been end labeled with digoxigenin/fluorescein by the TUNEL technique. (Lower) Same view-fields of CV-1 cells but counterstained with
Hoechst 33342. Fragmented DNA and apoptotic bodies (viewed at 510-560 nm) appear as yellow to greenish membrane-bound vesicle-like
elements. Red fluorescence represents intact DNA stained by propidium iodide. Total DNA, anti-digoxigenin/fluorescein-labeled and unlabeled
DNA was revealed as bright white fluorescence of Hoechst at 346-460 nm. (A) CV-1 cells cultured for 24 hr in the absence of toxin. (B) Cells
cultured for 3 hr in the presence of 1 ,uM TA. (C) Cells cultured for 3 hr in the presence of 1 ,uM FB1. (D) Cells cultured for 24 hr in the presence
of 5 ,uM FB1.
Temporal Progression of DNA Damage and Formation of
Apoptotic Bodies. In additional experiments, we observed that
cell death induced by either toxin occurred in stages with
chromatin condensation and cell shrinkage (Fig. 4 A and B).
These events were followed by the appearance of large bodies
which reacted positively to the TUNEL procedure (Fig. 4C),
indicating that they contained fragmented DNA. The initial
compaction of DNA and positive end labeling were observed
generally within the first 3-6 hr after toxin treatment. Fluo-







increasing fragmentation is reflected by changes in the color
of the fluorescence from yellow to green. The presence of
distinct, well separated apoptotic bodies (23) indicative of later
stages of programmed cell death, were observed (Fig. 4 D and
E) within 18 hr in each case. CV-1 cells treated with equivalent
concentrations of TA displayed morphological characteristics
of apoptosis identical to cells treated with FB1.
Effect of FB1 and TA on Cell Cycle Progression. Two recent
studies using mouse embryo cells (Swiss 3T3), which examined
the mitogenic potential of fumonisin, concluded in one case
C D E
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FIG. 4. Progression of nuclear DNA fragmentation in CV-1 cells treated with FB1. CV-1 cells were treated with 5 ,M FB1 for 24 hr and viewed
over this time period. (Upper) Toxin-treated CV-1 DNA that has been end labeled by the digoxigenin/fluorescein TUNEL technique. Fragmented
DNA and membrane-bound vesicle-like elements were viewed at 510-560 nm to reveal yellow to greenish fluorescence of anti-digoxigenin/
fluorescein. Unlabeled DNA stained by propidium iodide appears as red fluorescence material within the cells. (Lower) Same view fields using
Hoechst 33342 DNA counterstain. Total DNA, anti-digoxigenin/fluorescein-labeled, and unlabeled DNA were viewed at 346-460 nm as bright
white fluorescence of Hoechst. (A) Control cells. (B and C) Early stages of apoptosis where nuclear DNA fragments and nucleus budding are
revealed as yellow fluorescence. (D and E) Late stages of apoptosis ultimately revealing DNA fragments contained within membrane-bounded
apoptotic bodies with bright green fluorescence.
Biochemistry: Wang et al.
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Table 1. Cell cycle analysis in CV-1 or COS-7 cells after
fumonisin treatment
CV-1 cells COS-7 cells
G1 S G2/M Gi S G2/M
Control 81 16 3 55 22 23
12 hr 83 13 4 56 25 19
24 hr 90 7 3 61 24 15
48 hr 98 1 1 65 23 12
CV-1 or COS-7 cells were plated at a density of 5 x 105 cells per
100-mm dish and allowed to attach to the dish for 3 hr. Control, cells
treated with phosphate-buffered saline; 12 hr, cells treated for 12 hr
with 5 ,tM FBI; 24 hr, cells treated for 24 hr with 5 ,uM FBI; 48 hr, cells
treated for 48 hr with 5 ,uM FB1. Nuclei were prepared from the
respective cultures and flow cytometry was performed after nuclei
were incubated with a propidium iodide solution. Values are expressed
as % total cells and are from a representative experiment. At least
three independent determinations were performed.
that FB1 was mitogenic (17) while the other concluded that
FBI was not mitogenic (32). To investigate this interaction, we
examined the effect of FBI and TA treatment on cell cycle
progression. Flow cytometry was performed after CV-1 cells
were treated with 5 taM FB, or TA for 12, 24, or 48 hr. Our
results indicated that only FBI treatment induced arrest of cell
cycle in G, (Table 1). By 48 hr after treatment with FBI, only
1% of CV-1 cells were in S phase of the cell cycle. In contrast,
control cultures of CV-1 cells contained l15% of the cells in
S phase at the same time point. Similar concentrations of FB,
(or TA) did not increase the proportion of COS-7 cells in the
G, phase of the cell cycle following toxin treatment (Table 1).
As described above, COS-7 cells are monkey kidney cells
transformed by SV40 (33). When COS-7 cells were treated
with very high concentrations of FB1 (25 pAM), 16% of the cells
were in S phase compared to 34% in control cultures, sug-
gesting higher levels of FB1 will also arrest cell cycle in COS-7
cells. In contrast to FB1, similar concentrations of TA did not
dramatically alter the ratio of CV-1 or COS-7 cells in S phase
48 hr after treatment (Table 2). Even when treated with up to
25 aiM TA, they were not arrested in G1 (data not shown). In
summary, FB1, but not TA, inhibited cell cycle progression of
CV-1 cells while COS-7 cells were more resistant to the cell
cycle inhibitory effects of FB1.
DISCUSSION
These studies demonstrate that fumonisin B1 and TA induced
the stereotypical hallmarks of apoptosis in CV-1 cells, while
FBI, but not TA, induced cell cycle arrest at G1 in CV-1 cells.
The observation that FB1 can induce apoptosis raises the
question of how proliferating cells manage to avoid triggering
the apoptotic pathway that fumonisin can initiate in normal
Table 2. Cell cycle analysis in CV-1 or COS-7 cells after
TA treatment
CV-1 cells COS-7 cells
G1 S G2/M G1 S G2/M
Control 80 17 3 51 24 25
12 hr 81 15 4 54 27 19
24 hr 78 18 4 56 23 21
48 hr 82 15 3 55 21 24
CV-1 or COS-7 cells were plated at a density of 5 x 105 cells per
100-mm dish and allowed to attach to the dish for 3 hr. Control, cells
treated with phosphate-buffered saline; 12 hr, cells treated for 12 hr
with 5 p.M TA; 24 hr, cells treated for 24 hr with 5 ,LM TA; 48 hr, cells
treated for 48 hr with 5 ,uM TA. Nuclei were prepared from the
respective cultures and flow cytometry was performed after nuclei
were incubated with a propidium iodide solution. Values are expressed
as % total cells and are from a representative experiment. At least
three independent determinations were performed.
cells. This paradox may be reconciled by the fact that certain
genes involved in the induction of cell death also are respon-
sible for neoplastic transformation (34). For example, c-Myc,
a ubiquitous and essential mediator of cell proliferation also
induces programmed cell death (34). Tumor necrosis factor a
and mitosis-inducing agents such as caffeine and okadaic acid,
long recognized as tumor suppressors, can promote apoptosis
in HeLa cells (35, 36). The commitment of a cell to undergo
apoptosis is, in part, related to availability of growth factors,
age of the cell, cell type, stage of the cell cycle, and state of
differentiation (25, 34). It is unclear what specific genetic or
environmental factors determine whether FBj- or TA-treated
cells undergo proliferation or death.
Based on our previous results which indicated that FBI
inhibits AP-1-dependent transcription (27) and that the onset
of this inhibition temporally precedes the onset of cell death,
it is possible that the transcription factor AP-1 plays an
important role in determining whether CV-1 cells undergo
apoptosis or progress through the cell cycle. AP-1 binding
factors can promote G1 progression in some cell types but
induce differentiation in others (36). In addition, two isoforms
of PKC, a and 0, are repressed by fumonisin (27). Since PKC
activation results in rapid dephosphorylation of c-jun, a trans-
activator of AP-1 sites, it is possible that repression of AP-1-
dependent transcription by FB, is important for apoptosis.
Consistent with this possibility is-the fact that the same
concentration of toxin (5 ,tM) that inhibited PKC activity and
AP-1 transcription (27) also induced apoptosis. In addition, a
study by Walker et al. (37) demonstrated a correlation between
the presence of AP-1 DNA binding activity and repression of
apoptosis. Moreover, the ability of glucocorticoids to induce
apoptosis requires a glucocorticoid receptor that can repress
AP-1-dependent transcription (38). Also, the activation or
inhibition of PKC has been associated with the induction of
apoptosis (e.g., see ref. 39). Thus, it is possible that FBI induces
growth arrest and cell death, at least in part, by repressing AP-1
activity via inhibition of PKC.
An intriguing aspect of these data concerns the differing
results between CV-1 and COS-7 cells following FB1 treat-
ment. The SV40 large T antigen, which is expressed in COS-7
cells, binds to two tumor suppressor proteins known to regu-
late cell cycle progression and apoptosis (p53 and Rb, the
retinoblastoma susceptibility gene product). It is possible that
the association of large T antigen with one or more of these
proteins is responsible for the relative insensitivity of COS-7
cells to FBj, although we cannot rule out differential uptake
of the toxin.
TA is a structural analog of fumonisin B1 (Fig. 1), and
traditionally these toxins have been considered functionally
interchangeable with respect to specificity and biological ac-
tivity in both plant and animal cells. For example, both toxins
inhibit ceramide synthase and both toxins produce similar
symptoms on leaves and fruit of isogenic lines of tomato (21).
In this report, we have shown that both toxins cause apoptosis
in animal cells. Previously, we have reported that both toxins
also can initiate a cell death program in plants (7, 21). Although
both toxins induce apoptosis, only FBI affects the cell cycle.
Fumonisins are a serious health threat since corn and
corn-based food products are a common staple in the diet of
livestock animals and humans. Fumonisins are found fre-
quently in healthy as well as diseased corn plants. Preliminary
data indicate that both fumonisins and AAL toxins can be
found in concentrations sufficient to induce cell death in CV-1
cells and field samples of processing tomatoes and corn (refs.
4 and 40; B. Ward and D.G.G., unpublished data). The effect
of chronic exposure to these molecules on the health of
animals or humans is unresolved.
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